Crack, L.R.
70  Ergebnisse:
Personensuche X
?
 
?
2

Human antimicrobial peptides LL-37 and human β-defensin-2 r..:

Crack, L. R. ; Jones, L. ; Malavige, G. N...
Clinical and Experimental Dermatology.  37 (2012)  5 - p. 534-543 , 2012
 
?
3

Identification of an immunodominant region of the major hou..:

Crack, L. R. ; Chan, H. W. ; McPherson, T..
Clinical and Experimental Dermatology.  37 (2011)  3 - p. 266-276 , 2011
 
?
4

Phenotypic analysis of perennial airborne allergen‐specific..:

Crack, L. R. ; Chan, H. W. ; McPherson, T..
Clinical & Experimental Allergy.  41 (2011)  11 - p. 1555-1567 , 2011
 
?
5

3434 A UK national phase I/II clinical trial of a MEK1/2 in..:

Young, R. ; Poyser, C. ; Crack, L....
European Journal of Cancer.  51 (2015)  - p. S699 , 2015
 
?
6

Evaluation of a patient-held record for patients with cance:

LECOUTURIER, J. ; CRACK, L. ; MANNIX, K...
European Journal of Cancer Care.  11 (2002)  2 - p. 114-121 , 2002
 
?
8

The Emerging Role of the Gut–Brain–Microbiota Axis in Neuro..:

, In: Advances in Experimental Medicine and Biology; The Enteric Nervous System II,
Hosie, S. ; Abo-Shaban, T. ; Lee, C. Y. Q.... - p. 141-156 , 2022
 
?
11

Cover Image, Volume 527, Issue 5:

Webster, Kyria M. ; Sun, Mujun ; Crack, Peter J....
Journal of Comparative Neurology.  527 (2019)  6 - p. , 2019
 
?
12

Age‐dependent release of high‐mobility group box protein‐1 ..:

Webster, Kyria M. ; Sun, Mujun ; Crack, Peter J....
Journal of Comparative Neurology.  527 (2018)  6 - p. 1102-1117 , 2018
 
?
 
?
 
1-15